BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37960847)

  • 1. Chronic type 2 reaction in lepromatous leprosy with underlying
    Sagar HK; Pawar HS
    Trop Doct; 2024 Apr; 54(2):182-184. PubMed ID: 37960847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions.
    Kaplan G
    Lepr Rev; 2000 Dec; 71 Suppl():S117-20. PubMed ID: 11201867
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythema nodosum leprosum: reactional leprosy.
    Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
    Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept in erythema nodosum leprosum.
    Santos JRS; Vendramini DL; Nery JADC; Avelleira JCR
    An Bras Dermatol; 2017; 92(4):575-577. PubMed ID: 28954119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread Dermatophytosis in a Patient Treated for Leprosy Type II Reactional State after MDT/WHO-MB Release.
    Tavares Rodrigues F; Pereira Cardozo MR; da Costa Nery JA
    Am J Trop Med Hyg; 2018 Oct; 99(4):813-814. PubMed ID: 30292246
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythema nodosum leprosum and HIV infection: A therapeutic experience.
    Sharma NL; Mahajan VK; Sharma VC; Sarin S; Sharma RC
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):189-93. PubMed ID: 16830640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
    Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with erythema nodosus leprosum and Chagas cardiopathy: challenges in patient management and review of the literature.
    Trindade MÂ; Carvalho NB; Belfort EC; Pagliari C; Gakiya E; Sakai-Valente NY; Benard G; Shikanai-Yasuda MA
    Am J Trop Med Hyg; 2011 Jun; 84(6):973-7. PubMed ID: 21633036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.
    Putinatti MS; Lastória JC; Padovani CR
    An Bras Dermatol; 2014; 89(2):266-72. PubMed ID: 24770503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant PPD reaction with positive QuantiFERON-TB Gold in a patient with lepromatous leprosy.
    Murthy V; Horowitz HW; Pham VP; Levis WR
    J Drugs Dermatol; 2012 Oct; 11(10):1151-2. PubMed ID: 23285712
    [No Abstract]   [Full Text] [Related]  

  • 13. Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.
    Leon KE; Salinas JL; McDonald RW; Sheth AN; Fairley JK
    Am J Trop Med Hyg; 2015 Nov; 93(5):1082-6. PubMed ID: 26304919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Our experience of the use of thalidomide in the steroid-dependent severe erythema nodosum leprosum.
    Chaudhry NS; Rath SR; Visvanath V; Torsekar RG
    Indian J Dermatol Venereol Leprol; 2009; 75(2):189-90. PubMed ID: 19293514
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalidomide in erythema nodosum leprosum.
    Jew LJ; Middleton RK
    DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
    [No Abstract]   [Full Text] [Related]  

  • 16. An uncommon variant of erythema nodosum leprosum responding well to methotrexate: Report of two cases.
    Rani S; Singh S; Agrawal D; Sardana K; Ahuja A
    Trop Doct; 2021 Oct; 51(4):569-572. PubMed ID: 34102925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times.
    Sachdeva S; Sardana K; Kumari R; Bhogar K; Khurana A; Malhotra P
    Int J Dermatol; 2022 Nov; 61(11):e441-e443. PubMed ID: 35405022
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.